137 related articles for article (PubMed ID: 25408837)
1. Dihydropyrrolo[2,3-d]pyrimidines: Selective Toll-Like Receptor 9 Antagonists from Scaffold Morphing Efforts.
Watanabe M; Kasai M; Tomizawa H; Aoki M; Eiho K; Isobe Y; Asano S
ACS Med Chem Lett; 2014 Nov; 5(11):1235-9. PubMed ID: 25408837
[TBL] [Abstract][Full Text] [Related]
2. Single Stranded DNA Immune Modulators with Unmethylated CpG Motifs: Structure and Molecular Recognition by Toll-Like Receptor 9.
Fehér K
Curr Protein Pept Sci; 2019; 20(11):1060-1068. PubMed ID: 31470785
[TBL] [Abstract][Full Text] [Related]
3. [Multilevel maturation of Toll-like receptor 9].
Zyzak J; Matuszyk J; Siednienko J
Postepy Hig Med Dosw (Online); 2013 Oct; 67():1034-46. PubMed ID: 24184955
[TBL] [Abstract][Full Text] [Related]
4. Activity-guided development of potent and selective toll-like receptor 9 antagonists.
Paul B; Rahaman O; Roy S; Pal S; Satish S; Mukherjee A; Ghosh AR; Raychaudhuri D; Bhattacharya R; Goon S; Ganguly D; Talukdar A
Eur J Med Chem; 2018 Nov; 159():187-205. PubMed ID: 30292896
[TBL] [Abstract][Full Text] [Related]
5. New application of anti-TLR monoclonal antibodies: detection, inhibition and protection.
Fukui R; Murakami Y; Miyake K
Inflamm Regen; 2018; 38():11. PubMed ID: 29988708
[TBL] [Abstract][Full Text] [Related]
6. Innate immunity at the mucosal surface: role of toll-like receptor 3 and toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens.
Andersen JM; Al-Khairy D; Ingalls RR
Biol Reprod; 2006 May; 74(5):824-31. PubMed ID: 16421230
[TBL] [Abstract][Full Text] [Related]
7. TLR9 and the recognition of self and non-self nucleic acids.
Lamphier MS; Sirois CM; Verma A; Golenbock DT; Latz E
Ann N Y Acad Sci; 2006 Oct; 1082():31-43. PubMed ID: 17145922
[TBL] [Abstract][Full Text] [Related]
8. Immunostimulatory Activities of CpG-Oligodeoxynucleotides in Teleosts: Toll-Like Receptors 9 and 21.
Lai CY; Yu GY; Luo Y; Xiang R; Chuang TH
Front Immunol; 2019; 10():179. PubMed ID: 30800129
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor-9 induced by physical trauma mediates release of cytokines following exposure to CpG motif in mouse skin.
Liu L; Zhou X; Shi J; Xie X; Yuan Z
Immunology; 2003 Nov; 110(3):341-7. PubMed ID: 14632662
[TBL] [Abstract][Full Text] [Related]
10. Oligodeoxyribonucleotide-based antagonists for Toll-like receptors 7 and 9.
Wang D; Bhagat L; Yu D; Zhu FG; Tang JX; Kandimalla ER; Agrawal S
J Med Chem; 2009 Jan; 52(2):551-8. PubMed ID: 19102653
[TBL] [Abstract][Full Text] [Related]
11. Toll like receptor 9 antagonism modulates spinal cord neuronal function and survival: Direct versus astrocyte-mediated mechanisms.
Acioglu C; Mirabelli E; Baykal AT; Ni L; Ratnayake A; Heary RF; Elkabes S
Brain Behav Immun; 2016 Aug; 56():310-24. PubMed ID: 27044334
[TBL] [Abstract][Full Text] [Related]
12. The dysfunctional innate immune response triggered by Toll-like receptor activation is restored by TLR7/TLR8 and TLR9 ligands in cutaneous lichen planus.
Domingues R; de Carvalho GC; da Silva Oliveira LM; Futata Taniguchi E; Zimbres JM; Aoki V; da Silva Duarte AJ; Sato MN
Br J Dermatol; 2015 Jan; 172(1):48-55. PubMed ID: 24976336
[TBL] [Abstract][Full Text] [Related]
13. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.
Merlo A; Calcaterra C; Mènard S; Balsari A
J Leukoc Biol; 2007 Sep; 82(3):509-18. PubMed ID: 17586660
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity.
Krieg AM; Vollmer J
Immunol Rev; 2007 Dec; 220():251-69. PubMed ID: 17979852
[TBL] [Abstract][Full Text] [Related]
15. Cross talk between Leishmania donovani CpG DNA and Toll-like receptor 9: an immunoinformatics approach.
Gupta CL; Akhtar S; Waye A; Pandey NR; Pathak N; Bajpai P
Biochem Biophys Res Commun; 2015 Apr; 459(3):424-9. PubMed ID: 25735984
[TBL] [Abstract][Full Text] [Related]
16. Toll-Like receptor 2 (TLR2) and TLR9 play opposing roles in host innate immunity against Salmonella enterica serovar Typhimurium infection.
Zhan R; Han Q; Zhang C; Tian Z; Zhang J
Infect Immun; 2015 Apr; 83(4):1641-9. PubMed ID: 25667264
[TBL] [Abstract][Full Text] [Related]
17. CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10.
He B; Qiao X; Cerutti A
J Immunol; 2004 Oct; 173(7):4479-91. PubMed ID: 15383579
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor 2 suppresses Toll-like receptor 9 responses in Peyer's patch dendritic cells.
Kotaki R; Wajima S; Shiokawa A; Hachimura S
Immunobiology; 2015 Jun; 220(6):734-43. PubMed ID: 25638261
[TBL] [Abstract][Full Text] [Related]
19. Multiple Immunosuppressive Effects of CpG-c41 on Intracellular TLR-Mediated Inflammation.
Liu W; Yang X; Wang N; Fan S; Zhu Y; Zheng X; Li Y
Mediators Inflamm; 2017; 2017():6541729. PubMed ID: 28539706
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection.
Tabeta K; Georgel P; Janssen E; Du X; Hoebe K; Crozat K; Mudd S; Shamel L; Sovath S; Goode J; Alexopoulou L; Flavell RA; Beutler B
Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3516-21. PubMed ID: 14993594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
